Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 2
2021 8
2022 13
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Serological evidence of virus infection in Eidolon helvum fruit bats: implications for bushmeat consumption in Nigeria.
Cantoni D, Mayora-Neto M, Derveni M, da Costa K, Del Rosario J, Ameh VO, Sabeta CT, Auld B, Hamlet A, Jones IM, Wright E, Scott SD, Giotis ES, Banyard AC, Temperton N. Cantoni D, et al. Front Public Health. 2023 Nov 27;11:1283113. doi: 10.3389/fpubh.2023.1283113. eCollection 2023. Front Public Health. 2023. PMID: 38106901 Free PMC article.
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses.
Vishwanath S, Carnell GW, Ferrari M, Asbach B, Billmeier M, George C, Sans MS, Nadesalingam A, Huang CQ, Paloniemi M, Stewart H, Chan A, Wells DA, Neckermann P, Peterhoff D, Einhauser S, Cantoni D, Neto MM, Jordan I, Sandig V, Tonks P, Temperton N, Frost S, Sohr K, Ballesteros MTL, Arbabi F, Geiger J, Dohmen C, Plank C, Kinsley R, Wagner R, Heeney JL. Vishwanath S, et al. Among authors: cantoni d. Nat Biomed Eng. 2023 Sep 25. doi: 10.1038/s41551-023-01094-2. Online ahead of print. Nat Biomed Eng. 2023. PMID: 37749309
Evolutionary analysis of cellular reduction and anaerobicity in the hyper-prevalent gut microbe Blastocystis.
Záhonová K, Low RS, Warren CJ, Cantoni D, Herman EK, Yiangou L, Ribeiro CA, Phanprasert Y, Brown IR, Rueckert S, Baker NL, Tachezy J, Betts EL, Gentekaki E, van der Giezen M, Clark CG, Jackson AP, Dacks JB, Tsaousis AD. Záhonová K, et al. Among authors: cantoni d. Curr Biol. 2023 Jun 19;33(12):2449-2464.e8. doi: 10.1016/j.cub.2023.05.025. Epub 2023 Jun 1. Curr Biol. 2023. PMID: 37267944 Free article.
Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies.
Aguinam ET, Nadesalingam A, Chan A, Smith P, Paloniemi M, Cantoni D, Gronlund J, Gronlund H, Carnell GW, Castillo-Olivares J, Temperton N, Blacklaws B, Heeney JL, Baxendale H. Aguinam ET, et al. Among authors: cantoni d. J Allergy Clin Immunol Glob. 2023 May;2(2):100091. doi: 10.1016/j.jacig.2023.100091. Epub 2023 Mar 15. J Allergy Clin Immunol Glob. 2023. PMID: 37038555 Free PMC article.
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice.
Horvath D, Temperton N, Mayora-Neto M, Da Costa K, Cantoni D, Horlacher R, Günther A, Brosig A, Morath J, Jakobs B, Groettrup M, Hoschuetzky H, Rohayem J, Ter Meulen J. Horvath D, et al. Among authors: cantoni d. Sci Rep. 2023 Mar 21;13(1):4648. doi: 10.1038/s41598-023-31198-3. Sci Rep. 2023. PMID: 36944687 Free PMC article.
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants.
Carnell GW, Billmeier M, Vishwanath S, Suau Sans M, Wein H, George CL, Neckermann P, Del Rosario JMM, Sampson AT, Einhauser S, Aguinam ET, Ferrari M, Tonks P, Nadesalingam A, Schütz A, Huang CQ, Wells DA, Paloniemi M, Jordan I, Cantoni D, Peterhoff D, Asbach B, Sandig V, Temperton N, Kinsley R, Wagner R, Heeney JL. Carnell GW, et al. Among authors: cantoni d. Front Immunol. 2023 Feb 23;14:1118523. doi: 10.3389/fimmu.2023.1118523. eCollection 2023. Front Immunol. 2023. PMID: 36911730 Free PMC article.
Low hanging fruit for combatting SARS-CoV-2?
Cantoni D, Grove J. Cantoni D, et al. EMBO Rep. 2023 Apr 5;24(4):e56979. doi: 10.15252/embr.202356979. Epub 2023 Mar 6. EMBO Rep. 2023. PMID: 36876512 Free PMC article.
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms.
Cantoni D, Siracusano G, Mayora-Neto M, Pastori C, Fantoni T, Lytras S, Di Genova C, Hughes J, On Behalf Of The Ambulatorio Medico San Luca Villanuova Group, Lopalco L, Temperton N. Cantoni D, et al. Vaccines (Basel). 2022 Dec 27;11(1):58. doi: 10.3390/vaccines11010058. Vaccines (Basel). 2022. PMID: 36679903 Free PMC article.
Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies.
Nadesalingam A, Cantoni D, Aguinam ET, Chan AC, Paloniemi M, Ohlendorf L, George C, Carnell G, Lyall J, Ferrari M, Temperton N, Wagner R, Castillo-Olivares J, Baxendale H, Heeney JL. Nadesalingam A, et al. Among authors: cantoni d. Lancet Microbe. 2023 Feb;4(2):e58-e59. doi: 10.1016/S2666-5247(22)00297-X. Epub 2022 Nov 1. Lancet Microbe. 2023. PMID: 36332646 Free PMC article. No abstract available.
33 results